33. Infliximab 的臨床運用是基於抑制下列何者的作用?
(A) prostaglandin
(B) TNFα
(C) opioid
(D) vasopressin
答案:登入後查看
統計: A(1), B(40), C(0), D(0), E(0) #510328
統計: A(1), B(40), C(0), D(0), E(0) #510328
詳解 (共 2 筆)
#795470
nfliximab (INN; trade name Remicade) is a chimeric monoclonal antibody against tumour necrosis factor alpha (TNF-α) used to treat autoimmune diseases.
0
0